Menu

Top Stories

Published on Friday, November 8, 2019

Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

BARCELONA, Spain, Nov. 7, 2019 -- Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, has now introduced AlphaID™, a new, simple cheek swab that can be used by physicians to screen patients with chronic obstructive pulmonary disease (COPD) for Alpha-1 Antitrypsin Deficiency (Alpha-1), a rare, life-threatening genetic condition.

Now available for distribution in the U.S., the AlphaID™ cheek swab, which is completely free from ordering to results, is a simple way for physicians and healthcare providers to obtain a sufficient oral sample for Alpha-1 screening, taking only seconds to collect.

AlphaID™ utilizes an FDA-approved genotyping assay to screen for the 14 most prevalently reported genetic mutations associated with Alpha-1, including the S, Z, F, I alleles, as well as rare and null alleles, helping detect patients who are at risk for this treatable condition. AlphaID™ provides personal, comprehensive results within a week from the time the sample is sent in for screening.

"AlphaID™ is an innovative, convenient way for patients to be screened for Alpha-1, which could mean earlier diagnosis and management of COPD," said Angela Davis, MD, global medical director, Medical Affairs and Scientific Intelligence, Grifols. "For more than 20 years, Grifols has been a leader in Alpha-1 screening and is dedicated to helping patients understand their condition and make informed treatment decisions."

For patients who are found to have an at-risk genotype per the cheek swab results, Grifols offers an additional free test, known as AlphaID™ CONFIRM, to verify the patient's genotype and alpha-1 antitrypsin blood level to complete the diagnosis. AlphaID™ CONFIRM is a simple fingerstick blood collection kit, providing definitive and accurate results to patients who test positive with AlphaID™.

"Alpha-1 antitrypsin is a protective protein that plays a critical role in safeguarding the lungs, making it important to screen COPD patients for a deficiency," said Robert Sandhaus, professor of medicine, director, Alpha-1 Program, National Jewish Health. "Severe Alpha-1 is estimated to affect over 100,000 people in the U.S. alone, although more than 90% of individuals remain undiagnosed, even though a simple screening test will quickly detect the condition."

AlphaID™ was developed jointly by Grifols' Bioscience and Diagnostic divisions, including the company's Progenika unit, a leader in the diagnosis of genetic complex diseases.   

November marks National COPD Awareness Month, including COPD and genetic COPD due to Alpha-1. COPD is a condition that describes multiple lung diseases such as emphysema and chronic bronchitis. Alpha-1 is often not diagnosed because its symptoms are similar to COPD and asthma.

Only a physician or healthcare provider can make a diagnosis of Alpha-1. To learn more about AlphaID™ and the importance of testing for Alpha-1, please visit requestalphaid.com.

Source: PRNewswire 


Print

Open Enrollment: A video series by NHC

Friday, November 15, 2019
The National Health Council (NHC) created a short video series to help users navigate the health insurance marketplace for Open Enrollment, which runs from Friday, November 1st through Sunday, December 15th, this year. Open Enrollment...
Divider

State and city proclamations raise Alpha-1 awareness during Alpha-1 Awareness Month

Monday, November 11, 2019
November has been marked as Alpha-1 Awareness Month to increase knowledge and spread awareness about Alpha-1 Antitrypsin Deficiency (Alpha-1) with several activities across the United States. You can read the official press release here. Many...
Divider

Powerful video raises awareness of COPD and the need for research funding

Monday, November 11, 2019
November is National Alpha-1 Awareness Month and is also National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, and a powerful new video has been released that raises awareness of the critical need for significantly increased COPD...
Divider

Alpha-1 Awareness Month 2019: Virtual Walks week 1 (recap)

Saturday, November 9, 2019
November represents Alpha-1 Awareness Month and the community has set the tone for the month in week one. Alphas, friends, and family joined together on November 2nd around the country in their purple shirts to spread awareness and raise funds for...
Divider

Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

Friday, November 8, 2019
BARCELONA, Spain, Nov. 7, 2019 -- Grifols, a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, has now introduced AlphaID™, a new, simple cheek swab that can be used...
Divider

November is Alpha-1 Awareness Month

Friday, November 1, 2019
Miami, Nov. 1, 2019 – The month of November has been declared as Alpha-1 Awareness Month, by the Alpha-1 Foundation, to raise awareness about Alpha-1 Antitrypsin Deficiency (Alpha-1) throughout the United States. During November, several...
Divider

Mark Brantly, MD: Interim Scientific Director of the Alpha-1 Foundation

Wednesday, October 23, 2019
Mark Brantly, MD, has been named interim scientific director of the Alpha-1 Foundation, as Adam Wanner, MD, announced his resignation after 13 years of service to the Alpha-1 Foundation and the Alpha-1 community. Wanner served as scientific...
Divider

Jonathan Maidment completes a thru-hike of the Pacific Crest Trail raising awareness and funds for Alpha-1

Wednesday, October 16, 2019
October 16, 2019 – Hiking the Pacific Crest Trail (PCT) for the past seven months. Jonathan Maidment completes his journey to raise awareness and funds for Alpha-1 Antitrypsin Deficiency (Alpha-1). Holding up his Alpha Angels flag to honor...
Divider

Medicare: Open Enrollment for 2020

Monday, October 14, 2019
Medicare Open Enrollment begins on October 15, 2019 and ends on December 7, 2019. During this time, Medicare beneficiaries can compare coverage options like Original Medicare and Medicare Advantage and choose health and drug plans for...
Divider

Medicare Part D: Smoothing the out-of-pocket cap

Thursday, October 10, 2019
The Medicare Prescription drug benefit, or Part D, is an optional program from the Federal Government that helps older adults pay for their prescription drugs. Under Part D, the government and the individual share the cost of drugs up to a certain...
Divider

Escape to the Cape 2019: Team Alpha-1 at its best

Sunday, October 6, 2019
Even though the bike trek started with heavy hearts due to the very recent passing of two amazing Alpha volunteers, Susan Binnall and Alyce Yout, Team Alpha-1 pushed through and dedicated the ride to them: “Alyce & Sue This Rides for...
Divider

Open for comments: FDA proposes new required health warnings for cigarette packages

Tuesday, September 24, 2019
The U.S. Food and Drug Administration (FDA) issued a proposed rule to require new health warnings on cigarette packages and advertisements to promote greater public understanding of the negative health consequences of smoking. The agency...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive